Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment.

Abstract

Brain tumors represent the second most common cause of pediatric cancer death, with malignant gliomas accounting for ∼75% of pediatric deaths. Palbociclib, a selective cyclin-dependent kinase 4/6 (CDK4/6) inhibitor, has shown promise in phase I clinical trials of pediatric patients with progressive/refractory brain tumors using the oral administration route; however, pharmacokinetic limitations and toxicity issues remain. We synthesized a family of well-defined linear and star-shaped polyglutamate (PGA)-palbociclib conjugates using redox-sensitive self-immolative linkers to overcome limitations associated with free palbociclib. Exhaustive characterization of this conjugate family provided evidence for a transition towards the formation of more organized conformational structures upon increased drug loading. We evaluated the activity of conjugates in patient-derived glioblastoma and diffuse intrinsic pontine glioma cells, which display differing reducing environments due to differential glutathione expression levels. We discovered that microenvironmental parameters and the identified conformational changes determined palbociclib release kinetics and therapeutic output; furthermore, we identified a star-shaped PGA-palbociclib conjugate with low drug loading as an optimal therapeutic approach in diffuse intrinsic pontine glioma cells.

• Authors: Tetiana Melnyk, Esther Masiá, Oleksandr Zagorodko, Inmaculada Conejos-Sánchez, María J Vicent
• Journal: Journal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 355 Pg. 385-394 (03 2023) ISSN: 1873-4995 [Electronic] Netherlands
• PMID: 36746338 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2023. Published by Elsevier B.V.

Chemical References

• palbociclib
• Glutamic Acid

Topics

• Humans
• Child
• Glutamic Acid
• Diffuse Intrinsic Pontine Glioma
• Glioma (metabolism)
• Brain Neoplasms (metabolism)